BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29349894)

  • 1. Assessment of the potential of temporin peptides from the frog Rana temporaria (Ranidae) as anti-diabetic agents.
    Musale V; Casciaro B; Mangoni ML; Abdel-Wahab YHA; Flatt PR; Conlon JM
    J Pept Sci; 2018 Feb; 24(2):. PubMed ID: 29349894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulinotropic, glucose-lowering, and beta-cell anti-apoptotic actions of peptides related to esculentin-1a(1-21).NH
    Musale V; Abdel-Wahab YHA; Flatt PR; Conlon JM; Mangoni ML
    Amino Acids; 2018 Jun; 50(6):723-734. PubMed ID: 29549522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actions of PGLa-AM1 and its [A14K] and [A20K] analogues and their therapeutic potential as anti-diabetic agents.
    Owolabi BO; Musale V; Ojo OO; Moffett RC; McGahon MK; Curtis TM; Conlon JM; Flatt PR; Abdel-Wahab YHA
    Biochimie; 2017 Jul; 138():1-12. PubMed ID: 28392407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo insulinotropic properties of the multifunctional frog skin peptide hymenochirin-1B: a structure-activity study.
    Owolabi BO; Ojo OO; Srinivasan DK; Conlon JM; Flatt PR; Abdel-Wahab YH
    Amino Acids; 2016 Feb; 48(2):535-47. PubMed ID: 26439377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potent, non-toxic insulin-releasing peptide isolated from an extract of the skin of the Asian frog, Hylarana guntheri (Anura:Ranidae).
    Conlon JM; Power GJ; Abdel-Wahab YH; Flatt PR; Jiansheng H; Coquet L; Leprince J; Jouenne T; Vaudry H
    Regul Pept; 2008 Nov; 151(1-3):153-9. PubMed ID: 18501981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidomic analysis of skin secretions from the bullfrog Lithobates catesbeianus (Ranidae) identifies multiple peptides with potent insulin-releasing activity.
    Mechkarska M; Ojo OO; Meetani MA; Coquet L; Jouenne T; Abdel-Wahab YH; Flatt PR; King JD; Conlon JM
    Peptides; 2011 Feb; 32(2):203-8. PubMed ID: 21087647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tigerinin-1R: a potent, non-toxic insulin-releasing peptide isolated from the skin of the Asian frog, Hoplobatrachus rugulosus.
    Ojo OO; Abdel-Wahab YH; Flatt PR; Mechkarska M; Conlon JM
    Diabetes Obes Metab; 2011 Dec; 13(12):1114-22. PubMed ID: 21736689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-releasing properties of the frog skin peptide pseudin-2 and its [Lys18]-substituted analogue.
    Abdel-Wahab YH; Power GJ; Ng MT; Flatt PR; Conlon JM
    Biol Chem; 2008 Feb; 389(2):143-8. PubMed ID: 18163889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-releasing and cytotoxic properties of the frog skin peptide, tigerinin-1R: a structure-activity study.
    Srinivasan D; Ojo OO; Abdel-Wahab YH; Flatt PR; Guilhaudis L; Conlon JM
    Peptides; 2014 May; 55():23-31. PubMed ID: 24530698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic peptides with insulin-releasing activities from skin secretions of the Italian stream frog Rana italica (Ranidae).
    Conlon JM; Musale V; Attoub S; Mangoni ML; Leprince J; Coquet L; Jouenne T; Abdel-Wahab YHA; Flatt PR; Rinaldi AC
    J Pept Sci; 2017 Oct; 23(10):769-776. PubMed ID: 28699258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational analysis and in vitro immunomodulatory and insulinotropic properties of the frog skin host-defense peptide rhinophrynin-27 and selected analogs.
    Scorciapino MA; Carta P; Pantic J; Lukic ML; Lukic A; Musale V; Abdel-Wahab YHA; Conlon JM
    Biochimie; 2019 Dec; 167():198-206. PubMed ID: 31639404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caerulein precursor fragment (CPF) peptides from the skin secretions of Xenopus laevis and Silurana epitropicalis are potent insulin-releasing agents.
    Srinivasan D; Mechkarska M; Abdel-Wahab YH; Flatt PR; Conlon JM
    Biochimie; 2013 Feb; 95(2):429-35. PubMed ID: 23142129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial peptides from the skin of the Japanese mountain brown frog, Rana ornativentris.
    Kim JB; Iwamuro S; Knoop FC; Conlon JM
    J Pept Res; 2001 Nov; 58(5):349-56. PubMed ID: 11892844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities.
    Graham GV; Conlon JM; Abdel-Wahab YH; Flatt PR
    Eur J Pharmacol; 2020 Jul; 878():173101. PubMed ID: 32320703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulinotropic activity of the host-defense peptide frenatin 2D: Conformational, structure-function and mechanistic studies.
    Musale V; Guilhaudis L; Abdel-Wahab YHA; Flatt PR; Conlon JM
    Biochimie; 2019 Jan; 156():12-21. PubMed ID: 30244134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brevinin-2-related peptide and its [D4K] analogue stimulate insulin release in vitro and improve glucose tolerance in mice fed a high fat diet.
    Abdel-Wahab YH; Patterson S; Flatt PR; Conlon JM
    Horm Metab Res; 2010 Aug; 42(9):652-6. PubMed ID: 20496306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulinotropic actions of the frog skin host-defense peptide alyteserin-2a: a structure-activity study.
    Ojo OO; Abdel-Wahab YH; Flatt PR; Conlon JM
    Chem Biol Drug Des; 2013 Aug; 82(2):196-204. PubMed ID: 23742240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the insulinotropic and glucose-lowering actions of zebrafish GIP in mammalian systems: Evidence for involvement of the GLP-1 receptor.
    Graham GV; Conlon JM; Abdel-Wahab YH; Gault VA; Flatt PR
    Peptides; 2018 Feb; 100():182-189. PubMed ID: 29157578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of two novel antimicrobial peptides, temporin-Ra and temporin-Rb, from skin secretions of the marsh frog (Rana ridibunda).
    Asoodeh A; Zardini HZ; Chamani J
    J Pept Sci; 2012 Jan; 18(1):10-6. PubMed ID: 21956830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions.
    O'Harte FPM; Parthsarathy V; Hogg C; Flatt PR
    Peptides; 2018 Feb; 100():219-228. PubMed ID: 29412822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.